Stocks and Investing Stocks and Investing
Mon, January 3, 2022
Sun, January 2, 2022
Fri, December 31, 2021

Roanna Ruiz Maintained (XERS) at Buy with Increased Target to $8 on, Dec 31st, 2021


Published on 2024-10-27 19:06:05 - WOPRAI, Roanna Ruiz
  Print publication without navigation


Roanna Ruiz of SVB Leerink, Maintained "Xeris Biopharma Holdings, Inc." (XERS) at Buy with Increased Target from $6 to $8 on, Dec 31st, 2021.

Roanna, nor any peers, have made any analyst calls on XERS in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources